Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Di Tano

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Giornale Italiano Di Cardiologia (2006)|October 17, 2019
[The clinical care pathway of patients with chest pain]Giuseppe Di Tano, Roberto Bonatti
Giornale Italiano Di Cardiologia (2006)|April 12, 2017
[The relationship between natriuretic peptides and neprilysin pathways: the clinical simplification against the complexity of biological systems]Giuseppe Di Tano, Aldo Clerico
Giornale Italiano Di Cardiologia (2006)|September 6, 2011
[Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease]Giuseppe Di Tano, Silvia Frattini, Salvatore Pirelli
Giornale Italiano Di Cardiologia (2006)|April 13, 2012
[The relationship between the heart and the kidney in acute heart failure: doubts of the cardiologist and the nephrologist's point of view]Giuseppe Di Tano, Gianfranco Misuraca, , et al.
Giornale Italiano Di Cardiologia (2006)|May 18, 2013
[Data from the IN-HF Outcome registry]Gianfranco Misuraca, Giuseppe Di Tano, Alberto Camerini, et al.
European Journal of Case Reports in Internal Medicine|July 16, 2020
Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban TreatmentGiuseppe Di Tano, Luigi Moschini, Marco Loffi, et al.
Giornale Italiano Di Cardiologia (2006)|September 24, 2020
[Impact of the COVID-19 pandemic on the management of heart failure outpatient clinics. Lessons during the lockdown restrictions]Giuseppe Di Tano, Simone Verde, Marco Loffi, et al.
Giornale Italiano Di Cardiologia (2006)|September 30, 2010
[Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients]Nadia Aspromonte, Giuseppe Di Tano, Roberto Latini, et al.
Heart and Vessels|July 18, 2020
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infectionLuigi Moschini, Marco Loffi, Valentina Regazzoni, et al.
Giornale Italiano Di Cardiologia (2006)|October 15, 2013
[What cardiologists should know to manage acute complications in mechanical circulatory support recipients]Marco Marini, Claudia Raineri, Giuseppe Di Tano, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Giornale Italiano Di Cardiologia (2006)|October 17, 2019
[The clinical care pathway of patients with chest pain]Giuseppe Di Tano, Roberto Bonatti
Giornale Italiano Di Cardiologia (2006)|April 12, 2017
[The relationship between natriuretic peptides and neprilysin pathways: the clinical simplification against the complexity of biological systems]Giuseppe Di Tano, Aldo Clerico
Giornale Italiano Di Cardiologia (2006)|September 6, 2011
[Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease]Giuseppe Di Tano, Silvia Frattini, Salvatore Pirelli
Giornale Italiano Di Cardiologia (2006)|April 13, 2012
[The relationship between the heart and the kidney in acute heart failure: doubts of the cardiologist and the nephrologist's point of view]Giuseppe Di Tano, Gianfranco Misuraca, , et al.
Giornale Italiano Di Cardiologia (2006)|May 18, 2013
[Data from the IN-HF Outcome registry]Gianfranco Misuraca, Giuseppe Di Tano, Alberto Camerini, et al.
European Journal of Case Reports in Internal Medicine|July 16, 2020
Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban TreatmentGiuseppe Di Tano, Luigi Moschini, Marco Loffi, et al.
Giornale Italiano Di Cardiologia (2006)|September 24, 2020
[Impact of the COVID-19 pandemic on the management of heart failure outpatient clinics. Lessons during the lockdown restrictions]Giuseppe Di Tano, Simone Verde, Marco Loffi, et al.
Giornale Italiano Di Cardiologia (2006)|September 30, 2010
[Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients]Nadia Aspromonte, Giuseppe Di Tano, Roberto Latini, et al.
Heart and Vessels|July 18, 2020
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infectionLuigi Moschini, Marco Loffi, Valentina Regazzoni, et al.
Giornale Italiano Di Cardiologia (2006)|October 15, 2013
[What cardiologists should know to manage acute complications in mechanical circulatory support recipients]Marco Marini, Claudia Raineri, Giuseppe Di Tano, et al.
Pageof 8